He joins the US biotech from private investment firm Colchester Healthcare Investments" /> He joins the US biotech from private investment firm Colchester Healthcare Investments" />

Please login to the form below

Not currently logged in
Email:
Password:

Ischemix names David DeWahl as CEO

He joins the US biotech from private investment firm Colchester Healthcare Investments

David DeWahl has been appointed president and CEO of US biotech Ischemix.

He joins after stepping down from his role as president of private investment firm Colchester Healthcare Investments.

He has also previously served as VP corporate development at Helix Therapeutics and managing director at Life Science Group – a company he co-founded.

Prior to that, DeWahl was an investment banker with a focus on healthcare the life sciences.

“His background in building life sciences companies and his experience in developing corporate collaborations in the industry and in raising capital will substantially strengthen Ischemix as we continue the clinical development of our drug candidates,” said Dr Reinier Beeuwkes, chairman of the board and chief scientific officer at Ischemix.

These candidates include the company's lead compound CMX-2043, which is being developed to protect against heart and kidney damage due to the interruption of blood flow.

The investigational drug has recently demonstrated positive benefits in phase IIa trials, and further development is expected this year.

11th January 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics